Sharon Benzeno, Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corp (ADPT), sold 63,103 shares at $13.17 ($831K) on 2026-03-11, disclosed to the SEC on 2026-03-13.
Seasonal sale ($831k) by Chief Commercial Ofc Imm Med — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |
| ADPT | SELL | 2024-03-06 | $165K | — | Filing → |